trabectedin what is is used for
Trabectedin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Trabectedin is used to treat liposarcoma, a rare type of cancer that grows in fatty tissues of the body. Trabectedin is also used to treat leiomyosarcoma, a rare fast-growing type of cancer that grows in many tissues of the body, including fat, muscle, bone, joints, and blood vessels. Trabectedin is used to treat cancer that has spread to other parts of the body or cannot be treated with surgery. Trabectedin may also be used for purposes not listed in this medication guide. Serious and sometimes fatal infections may occur during treatment with trabectedin.
FDA Approval for Trabectedin. Use in Cancer. Trabectedin is approved to treat: Liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have metastasized (spread to other parts of the body). It is used in patients who have already been treated with anthracycline chemotherapy. Trabectedin is also being studied in the treatment of other types of cancer. More About Trabectedin. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. MedlinePlus Information on Trabectedin - A lay language summary of important information about this drug that may include the following: warnings about this drug, what this drug is used for and how it is used,